Clinical Trials and Retatrutide Retatrutide's clinical trials, including the notable TRIUMPH-1, set the stage for its effectiveness and safety evaluations
Dosing tiers: Oral administration (500 mcg to 1.5 mg/day) targets gut-specific inflammation: IBD, colitis, and intestinal barrier dysfunction
Some cautionary words: The number one barrier to using weight loss meds is the cost, Dr
Blood glucose should be checked regularly, particularly in patients on concurrent diabetes medications, with appropriate treatment of hypoglycemia using oral glucose or intravenous dextrose as clinically indicated
A lazy GLP-1 diet plan works better when at least one solid protein shows up every time you eat
16 Finally, compared to other GLP-1 receptor agonists like dulaglutide, semaglutide is generally more potent, longer-acting, and often leads to greater HbA1c reductions and weight loss